Eterna Therapeutics
ERNA
#11150
Rank
โ‚ฌ2.69 M
Marketcap
1,65ย โ‚ฌ
Share price
-1.60%
Change (1 day)
14.31%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2023 (TTM): -5,46ย โ‚ฌ

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -26,15ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -49,49ย โ‚ฌ.

EPS history for Eterna Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-5,46ย โ‚ฌ
2021-49,49ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,70ย โ‚ฌ-106.50%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-1,26ย โ‚ฌ-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
1,53ย โ‚ฌ-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-0,09822ย โ‚ฌ-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
0,56ย โ‚ฌ-102.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
1,04ย โ‚ฌ-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA